Fairvalue-Calculator Fairvalue-Calculator
EN DE

3billion, Inc (394800) Fair Value & Analysis

Healthcare · KR · Market cap 236B KRW

Price6,390 KRW
Fair Value2,229 KRW
Upside-65.1%
Quality95/100
Evidence: Low Range 1,672 KRW – 2,786 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

3billion, Inc (394800) currently trades at 6,390 KRW, while our model-based Fair Value estimate is 2,229 KRW — implying the stock looks roughly 65.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is 3billion, Inc (394800) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,229 KRW versus a price of 6,390 KRW — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 394800?
Our 21-model fair value for 3billion, Inc is 2,229 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 6,390 KRW.
What is the quality score of 394800?
3billion, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.